Search

10 results on this page

Shiyao's AI Drug Bet Needs Real Products

Shiyao's AI Drug Bet Needs Real Products

石藥創新上半年營收與淨利大幅增長,主要由巨石生物與AstraZeneca合作取得的4.2億美元首付款帶動,而非已上市藥品銷售。這項合作凸顯其AI多肽發現平台與LiquidGel長效遞送技術的價值,但公司仍需依靠ADC等候選藥物上市,才能從出售管線轉向銷售產品。

Anthropic Targets a Record-Breaking IPO

Anthropic Targets a Record-Breaking IPO

Anthropic reportedly expects its IPO to match or exceed SpaceX's record $75 billion raise and could file publicly as soon as the end of this month. The company reportedly recorded an almost $42 billion net loss in 2025, about five times the previous year's figure.

The Next Web (TNW)Media2h ago#ipo#frontier-ai#fundraising
Page 1